ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Wisconsin » Hematology Oncology

Top Hematology Oncology Prescribers in Wisconsin

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LINH KHUU MD

Hematology Oncology

247

$77.6K

63
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 15%

$314
Average prescription price

Avg: $356

SAILAJA KAMARAJU MD

Hematology Oncology

275

$30.8K

72
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 15%

$112
Average prescription price

Avg: $356

TIMOTHY FENSKE MD

Hematology Oncology

296

$177K

49
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 15%

$597
Average prescription price

Avg: $356

AMY HARKER-MURRAY MD

Hematology Oncology

333

$105K

61
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 15%

$315
Average prescription price

Avg: $356

MICHAEL OJELABI M.D

Hematology Oncology

362

$34.6K

81
71 are 65+

17%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

7%
prescriptions for brand name drugs

Avg: 15%

$96
Average prescription price

Avg: $356

ROBERT GELLER MD

Hematology Oncology

369

$210K

76
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 15%

$569
Average prescription price

Avg: $356

GOPAKUMAR NAMBUDIRI MD

Hematology Oncology

388

$89.3K

82
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

11%
prescriptions for brand name drugs

Avg: 15%

$230
Average prescription price

Avg: $356

YEE CHUNG CHENG MD

Hematology Oncology

396

$38.3K

88
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 15%

$97
Average prescription price

Avg: $356

KARI WISINSKI MD

Hematology Oncology

410

$87.8K

63
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 15%

$214
Average prescription price

Avg: $356

THOMAS ZUKOWSKI MD

Hematology Oncology

453

$161K

77
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 15%

$356
Average prescription price

Avg: $356

KURT OETTEL MD

Hematology Oncology

466

$59.2K

96
83 are 65+

11%
patients receiving schedule two controlled substances

Avg: 13%

11%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 15%

$127
Average prescription price

Avg: $356

STEPHEN TOOTHAKER M.D.

Hematology Oncology

484

$230K

112
91 are 65+

12%
patients receiving schedule two controlled substances

Avg: 13%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 15%

$476
Average prescription price

Avg: $356

MUHAMMAD MOID MD

Hematology Oncology

512

$53.9K

124
107 are 65+

15%
patients receiving schedule two controlled substances

Avg: 13%

15%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 15%

$105
Average prescription price

Avg: $356

EHAB ATALLAH MD

Hematology Oncology

515

$934K

69
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 15%

$1813
Average prescription price

Avg: $356

JOHN BURFEIND MD

Hematology Oncology

516

$357K

91
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 15%

$691
Average prescription price

Avg: $356

JAMES HEUN M.D.

Hematology Oncology

526

$126K

125
111 are 65+

19%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 15%

$239
Average prescription price

Avg: $356

EMILY ROBINSON MD

Hematology Oncology

531

$147K

68
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 15%

$276
Average prescription price

Avg: $356

ARLENE GAYLE MD

Hematology Oncology

543

$311K

86
66 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 15%

$573
Average prescription price

Avg: $356

COLIN MOONEY MD

Hematology Oncology

554

$187K

91
77 are 65+

16%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 15%

$337
Average prescription price

Avg: $356

YAMIL ARBAJE MD

Hematology Oncology

557

$242K

134
118 are 65+

13%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 15%

$435
Average prescription price

Avg: $356

AMY STELLA M.D.

Hematology Oncology

558

$81.2K

113
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 15%

$145
Average prescription price

Avg: $356

UMANG GAUTAM MD

Hematology Oncology

562

$38.5K

83
60 are 65+

22%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 15%

$69
Average prescription price

Avg: $356

WILLIAM HOCKING MD

Hematology Oncology

563

$206K

84
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 15%

$366
Average prescription price

Avg: $356

NANCY DAVIS MD

Hematology Oncology

581

$80.1K

113
87 are 65+

20%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 15%

$138
Average prescription price

Avg: $356

RIFAT ELKHATIB MD

Hematology Oncology

582

$164K

112
91 are 65+

14%
patients receiving schedule two controlled substances

Avg: 13%

0%
patients receiving schedule three controlled substances

Avg: 7%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

9%
prescriptions for brand name drugs

Avg: 15%

$281
Average prescription price

Avg: $356

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank